Latest / Philadelphia News Today | 2 Min News | The Daily News Now!
Moderna’s mRNA Flu Shot Approved | Philadelphia News
Moderna’s groundbreaking mRNA flu vaccine just got FDA approval—targeting adults 50 and up—and could hit stores in weeks, offering 27% better protection than the standard shot. After a rocky path amid mRNA skepticism, the company struck a deal for accelerated approval in older adults, with more studies promised. Side effects like soreness and fatigue were common, and while Medicare will cover it, insurance and pharmacy access vary. This milestone shows how fast science moves—but also how politics and public trust shape health decisions. Listen in comfort:Get a discount on a Soli Pillow…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.